Загрузка...
Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are major contributors to the burden of liver disease today. Effective therapeutic strategies for prevention of progression of NASH to cirrhosis are still elusive. As with other diseases causing cirrhosis, NASH also inc...
Сохранить в:
| Опубликовано в: : | J Clin Exp Hepatol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7527837/ https://ncbi.nlm.nih.gov/pubmed/33029058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2020.04.004 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|